or
forgot password

    • cancer clinical trials in lafayette, IN

    • Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    Clarian Arnett Cancer Care
    Lafayette, Indiana 47904
    Breast Cancer
    Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
    Oncology Institute of Greater Lafayette
    Lafayette, Indiana 47904
    Kidney Cancer
    Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
    Clarian Arnett Cancer Care
    Lafayette, Indiana 47904
    Lymphoma
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Clarian Arnett Cancer Care
    Lafayette, Indiana 47904
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
    Arnett Cancer Care
    Lafayette, Indiana 47904
    Chronic Lymphocytic Leukemia
    Quality of Life in Female Breast Cancer Survivors and Their Spouse, Partner, or Acquaintance
    Clarian Arnett Cancer Care
    Lafayette, Indiana 47904
    Breast Cancer, Cancer Survivor, Cognitive/Functional Effects, Psychosocial Effects of Cancer and Its Treatment, Sexuality and Reproductive Issues, Spiritual Concerns
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Horizon Oncology Center

    Trial Locations
    Horizon Oncology Center
    IU Health Arnett
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    IU Health Arnett
    Lafayette, Indiana
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Horizon Oncology Center

    Trial Locations
    Horizon Oncology Center
    IU Health Arnett
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Phase I/Randomized Phase II Study of Second Line Therapy With Irinotecan + Cetuximab +/- RAD001 for Colorectal Cancer
    Arnett Cancer Care

    Trial Locations
    Arnett Cancer Care
    Horizon Oncology Center
    Colorectal Cancer
    Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
    IU Health Arnett
    Lafayette, Indiana
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer
    Horizon Oncology Researcg

    Trial Locations
    Horizon Oncology Researcg
    IU Health Arnett Cancer Center
    Small Cell Lung Cancer
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    IU Health Arnett
    Lafayette, Indiana
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Pharmatech Oncology Study Site
    Lafayette, Indiana 47904
    Diffuse Large B-Cell Lymphoma
    Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
    Clarian Arnett Cancer Care
    Lafayette, Indiana 47904
    Breast Cancer, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Musculoskeletal Complications, Pain, Prostate Cancer, Urinary Complications
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    IU Health Arnett
    Lafayette, Indiana
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
    Clarian Arnett Cancer Care
    Lafayette, Indiana 47904
    Chemotherapeutic Agent Toxicity, Fallopian Tube Cancer, Neurotoxicity, Ovarian Cancer, Pain, Peripheral Neuropathy, Primary Peritoneal Cavity Cancer
    PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 Mutations
    Horizon Oncology Research, Inc./IU Health Arnett
    Lafayette, Indiana 47905
    Breast Cancer
    Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
    Clarian Arnett Cancer Care
    Lafayette, Indiana 47904
    Chemotherapeutic Agent Toxicity, Colorectal Cancer, Neuropathy, Neurotoxicity
    Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
    IU Health Arnett
    Lafayette, Indiana
    Light Chain Deposition Disease, Smoldering Multiple Myeloma
    Bendamustine in Combination With Bortezomib and Pegylated Liposomal Doxorubicin for Multiple Myeloma
    IU Health Arnett Cancer Center
    Lafayette, Indiana 47904
    Multiple Myeloma
    Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer
    Horizon Oncology Center
    Lafayette, Indiana 47905
    Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer, Stage III Prostate Cancer
    Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
    Horizon Oncology Center Horizon Onc
    Lafayette, Indiana 47905
    Non-small Cell Lung Cancer
    A Study of MM-111 in Combination With Multiple Treatments in Patients With HER2 Positive Cancer
    Horizon Oncology Research, Inc
    Lafayette, Indiana 47905
    HER-2 Gene Amplification
    Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
    Horizon Oncology Center
    Lafayette, Indiana 47905
    B Cell Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Waldenstrom Macroglobulinemia
    Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment
    Horizon Oncology Research, Inc.
    Lafayette, Indiana
    Advanced Solid Tumors
    Phase Ib of Abiraterone Acetate Plus BEZ235 or BKM120 in Castration-resistant Prostate Cancer (CRPC) Patients
    Horizon Oncology Center Horizon Onc
    Lafayette, Indiana 47905
    Castration-resistant Prostate Cancer
    Safety Study of CC-292 and Lenalidomide in Subjects With Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma
    Horizon Oncology Research
    Lafayette, Indiana 47905
    Leukemia Lymphocytic Chronic B-Cell
    Study of PNT2258 for Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma
    Horizon Oncology Research, Inc.
    Lafayette, Indiana
    Lymphoma, Non-Hodgkin's
    Safety Study of CC-292 and Rituximab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
    Horizon Oncology Research, Inc
    Lafayette, Indiana 47905
    Leukemia Lymphocytic Chronic B-Cell
    Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer
    Oncology Institute of Greater Lafayette
    Lafayette, Indiana 47904
    Breast Cancer, Metastatic Cancer, Pain, Prostate Cancer
    Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
    Oncology Institute of Greater Lafayette
    Lafayette, Indiana 47904
    Colorectal Cancer
    Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    Oncology Institute of Greater Lafayette
    Lafayette, Indiana 47904
    Breast Cancer
    Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
    Oncology Institute of Greater Lafayette
    Lafayette, Indiana 47904
    Head and Neck Cancer, Oral Complications, Radiation Toxicity
    Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor
    Oncology Institute of Greater Lafayette
    Lafayette, Indiana 47904
    Carcinoma of Unknown Primary
    Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer
    Oncology Institute of Greater Lafayette
    Lafayette, Indiana 47904
    Cachexia, Lymphoma, Lymphoproliferative Disorder, Unspecified Adult Solid Tumor, Protocol Specific